EHTH at a glance
eHealth, Inc. (EHTH, SEC CIK 1333493) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as October 13, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), eHealth, Inc. (EHTH) reported revenue of $554.0 million (up 4.1% from FY2024) and net income of $40.0 million. Diluted EPS was -$0.34.
- As of September 30, 2026, 19 institutional investment managers tracked by SignalX reported holding eHealth, Inc. (EHTH) shares worth $3.9 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by SOISTMAN FRANCIS S JR on October 2, 2026 of 20,306 shares at $0.69 per share.
- In the last 90 days, EHTH insiders reported 0 open-market purchases ($0) and 4 open-market sales ($110K) on Form 4, a net sale of $110K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $554.0M
- +4.1% vs prior year
- Insiders · 90 days
- 0 buys · 4 sells
- Net −$110K
- 13F holders
- 19 funds
- $3.9M · −4 vs prior quarter
- Latest 8-K
- Nov 4, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Online health insurance brokerage earning commissions from insurance policy sales as broker of record
- Enhanced focus this year on refining lifetime value (LTV) commission revenue estimates using cohort and statistical modeling approaches
- No new products or business segments introduced or emphasized in fiscal 2026 filing
- No material changes to critical accounting policies or estimates for revenue recognition, stock-based compensation, or income tax accounting
- Noteworthy use of advanced judgment and analysis to update constraints and assumptions impacting commission revenue recognition under ASC 606
Risk Factors
- Regulatory risk from CMS Medicare marketing compliance potentially causing carrier relationship termination or corrective actions due to complaints or violations
- Macroeconomic exposure from AI-driven search changes reducing website traffic, increasing member acquisition costs, and harming marketing effectiveness
- Operational vulnerability in recruiting, certifying, and retaining licensed benefit advisors during highly seasonal fourth quarter enrollment peak
- Competitive threat from government-run Medicare and ACA exchanges with greater resources and direct carrier sales reducing traffic and conversions
- Financial concentration risk with majority revenue from top carriers Humana, UnitedHealthcare, and Aetna, whose contract changes or business impairment could materially impact results
AI summary of the EHTH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Revenue $21.3M, down 60% YoY from $53.9M, driven by Medicare commission revenue decline
- Net loss $35.9M, with operating loss $46.3M versus $41.5M; operating margin (218)% vs (77)% YoY
- Medicare worst performer: revenue $18.1M, down 64%, segment gross loss $12.7M vs $1.2M loss
- Cash, equivalents and securities $88.1M vs $77.2M at December 31; operating cash flow $19.6M vs $10.6M
- Near-term focus: fourth-quarter AEP, lifetime advisory model, CHOICE expansion; Medicare enrollment lower amid reduced marketing spend and regulatory headwinds
Risk Factors
- Newly added regulatory risk: CMS moratorium on new FFM agent registrations announced September 2026, lasting until February 1, 2027
- Most material legal update: U.S. Attorney intervened in part in the False Claims Act qui tam action on May 1, 2025
- Operational risk: Fourth-quarter enrollment concentration may require rapid hiring and training of temporary benefit advisors
- Financial risk: $125.0 million revolving facility matures December 2028, with leverage, liquidity and LTV covenants
- Concentration risk: Humana, UnitedHealthcare and Aetna accounted for a majority of total revenue in 2025 and 2024
AI summary of the EHTH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 and nine-month 2026 financial results announced for periods ended September 30, 2026
- Financial condition reported as of September 30, 2026
Item EX-99.1: Item EX-99.1
- Q3 revenue fell 60% to $21.3M, reflecting deliberate marketing reductions outside enrollment periods but sharply lower near-term scale
- GAAP net loss widened to $35.9M from $31.7M, while adjusted EBITDA declined to $(39.9)M from $(34.0)M
Item EX-99.2: Item EX-99.2
- Q3 2026 revenue fell 60% to $21.3M as eHealth deliberately reduced off-season marketing investment
- Cost reductions lowered operating expenses 29% to $67.6M, with approximately $90.0M FY2026 savings targeted
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule
- Nasdaq deficiency: EHTH closed below the $1.00 minimum bid for 30 consecutive business days
- No immediate delisting: shares remain on Nasdaq Global Select under ticker EHTH
Item EX-99.1: Item EX-99.1
- Q2 revenue fell 45% to $33.6M as eHealth reduced off-season Medicare marketing and enrollment volume
- Net loss widened to $23.6M from $17.4M, while adjusted EBITDA declined to $(21.8)M from $(14.1)M
Item 2.02: Results of Operations and Financial Condition
- eHealth announced financial results for the three and six months ended June 30, 2026
- Financial condition reported as of June 30, 2026
AI summaries of EHTH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for EHTH
Don't miss the next EHTH filing
- Alerts as it files. A push when EHTH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut EHTH, by share count.
- Ask anything. An AI agent that reads every EHTH filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Galimi Gavin G. | F | Oct 10, 2026 | 842 | $0.70 |
| Dolan John Joseph | F | Oct 10, 2026 | 465 | $0.70 |
| Barbeau Michelle Marie | F | Oct 10, 2026 | 323 | $0.70 |
| SOISTMAN FRANCIS S JR | Sell | Oct 2, 2026 | 20,306 | $0.69 |
| SOISTMAN FRANCIS S JR | Sell | Oct 1, 2026 | 20,306 | $0.70 |
| Dolan John Joseph | F | Sep 10, 2026 | 5,859 | $0.92 |
| Barbeau Michelle Marie | F | Sep 10, 2026 | 4,312 | $0.92 |
| Dolan John Joseph | A | Sep 1, 2026 | 70,000 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $532.4M | $554.0M |
| Gross Profit | - | $208.5M | $240.8M |
| Operating Income | - | $23.6M | $66.5M |
| Net Income | - | $10.1M | $40.0M |
| Gross Margin | - | 39.2% | 43.5% |
| Op. Margin | - | 4.4% | 12.0% |
| Net Margin | - | 1.9% | 7.2% |
| Balance Sheet | |||
| Total Assets | - | $1.2B | $1.3B |
| Equity | - | $588.4M | $591.6M |
| ROE | - | 1.7% | 6.8% |
| Per Share | |||
| EPS | $-2.37 | $-1.19 | $-0.34 |
| Cash Flow | |||
| Operating CF | - | -$18.4M | -$25.3M |
| CapEx | $2.1M | $2.1M | $2.3M |
Source: XBRL data in eHealth, Inc. (EHTH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate EHTH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 19 | $3.9M |
| Q2 2026 | 23 | $11.3M |
| Q1 2026 | 21 | $11.4M |
| Q4 2025 | 25 | $36.5M |
| Q3 2025 | 22 | $35.9M |
| Q2 2025 | 23 | $36.1M |
| Q1 2025 | 20 | $35.0M |
| Q4 2024 | 16 | $37.7M |
- D.E. Shaw & Co+72.8K (+13%)
- Citigroup+3.0K (+300200%)
- AQR Capital Management−1.36M (-59%)
- Goldman Sachs Group−210.5K (-47%)
- Dimensional Fund Advisors−162.3K (-29%)
- Citadel Advisors LLC−135.9K (-66%)
- Bank of America Corp−114.1K (-67%)
- Two Sigma Investments+99.0K
- Franklin Resources−28.0K
- StoneX Group Inc.−13.0K
- BNY Mellon−10.0K
- FMR LLC (Fidelity)−4.7K
- Wells Fargo & Co−20
Source: 13F-HR filings on SEC EDGAR (aggregated from 169 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
EHTH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 10-Q | Nov 5, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 8-K | Oct 16, 2026 | - | Analysis | - |
| 4 | Oct 13, 2026 | - | - | - |
| 4 | Oct 13, 2026 | - | - | - |
| 4 | Oct 13, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Sep 11, 2026 | - | - | - |
| 4 | Sep 11, 2026 | - | - | - |
| 4 | Sep 3, 2026 | - | - | - |
| 4 | Sep 3, 2026 | - | - | - |
| 4 | Sep 3, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Aug 5, 2026 | - | - | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 4 | Jul 14, 2026 | - | - | - |
| 4 | Jul 14, 2026 | - | - | - |
| 4 | Jul 14, 2026 | - | - | - |
| 8-K | Jun 25, 2026 | - | Analysis | - |
| 4 | Jun 23, 2026 | - | - | - |
| 4 | Jun 23, 2026 | - | - | - |
| 4 | Jun 23, 2026 | - | - | - |
| 4 | Jun 23, 2026 | - | - | - |
| 4 | Jun 23, 2026 | - | - | - |
Related Financials companies
- AON · Aon plcInsurance Agents, Brokers & Service
- AJG · Arthur J. Gallagher & Co.Insurance Agents, Brokers & Service
- BWIN · Baldwin Insurance Group, Inc.Insurance Agents, Brokers & Service
- BRO · Brown & BrownInsurance Agents, Brokers & Service
- CRVL · CORVEL CORPInsurance Agents, Brokers & Service
- ACT · Enact Holdings, Inc.Insurance Agents, Brokers & Service
- EQH · Equitable Holdings IncInsurance Agents, Brokers & Service
- ERIE · Erie IndemnityInsurance Agents, Brokers & Service
EHTH SEC filings: frequently asked questions
Are EHTH insiders buying or selling?
In the last 90 days, eHealth, Inc. (EHTH) officers, directors and 10% owners reported no open-market purchases and 4 open-market sales worth $109,884 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold EHTH stock?
As of September 30, 2026, the largest eHealth, Inc. (EHTH) holders among the 13F filers tracked by SignalX were BlackRock ($916,000), Vanguard Capital Management LLC ($820,000), AQR Capital Management ($661,000), D.E. Shaw & Co ($455,000), Dimensional Fund Advisors ($276,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was EHTH's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), eHealth, Inc. (EHTH) reported revenue of $554.0 million (up 4.1% from FY2024) and net income of $40.0 million. Diluted EPS was -$0.34. The figures come from the XBRL data in the 10-K.
What are the main risks in EHTH's latest 10-K?
In the 10-K filed February 26, 2026, eHealth, Inc. (EHTH) flagged: Regulatory risk from CMS Medicare marketing compliance potentially causing carrier relationship termination or corrective actions due to complaints or violations. Macroeconomic exposure from AI-driven search changes reducing website traffic, increasing member acquisition costs, and harming marketing effectiveness. (AI summary of the Risk Factors section.)
What did EHTH report in its latest 8-K?
eHealth, Inc. (EHTH) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 and nine-month 2026 financial results announced for periods ended September 30, 2026.
What are the latest EHTH SEC filings?
eHealth, Inc. (EHTH) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on October 13, 2026.
What is EHTH's SEC CIK number?
eHealth, Inc. (EHTH)'s SEC Central Index Key (CIK) is 1333493. EDGAR lists every EHTH filing under that number.
Ask anything about EHTH
The research agent reads EHTH's filings, financials, insider trades and 13F holders, then answers with sources.